Form 4: MicroVision Director Peter Schabert Reports Significant RSU Vesting and New Equity Grant

MicroVision, Inc. Director Peter Schabert disclosed the vesting of 20,112 restricted stock units into common stock and the grant of 87,642 new restricted stock units, increasing his total beneficial ownership.

Summary

• Peter Schabert, a Director of MicroVision, Inc. (MVIS), reported changes in his beneficial ownership of company securities via a Form 4 filing.
• On June 5, 2025, 20,112 restricted stock units (RSUs) vested and converted into an equal number of common shares, without payment. These RSUs were part of a grant from September 3, 2024, which vested partially upon grant and the remainder in equal quarterly installments, contingent on his continued service as a director.
• Following this vesting, Mr. Schabert's direct beneficial ownership of common stock increased to 80,450 shares.
• On June 6, 2025, Mr. Schabert was granted an additional 87,642 restricted stock units.
• These newly granted RSUs are scheduled to vest in four equal quarterly installments until the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, also contingent on his continued service as a director.
• Each RSU represents a contingent right to receive one share of MicroVision common stock upon vesting.

Sentiment

Score: 7

Explanation: The filing indicates a routine but positive event where a director's equity stake in the company increased through RSU vesting and a new grant, aligning their interests with shareholders. This generally signals confidence from an insider.

Positives

• Director Peter Schabert's beneficial ownership of common stock increased to 80,450 shares following the vesting of 20,112 restricted stock units, aligning his interests further with shareholders.
• The grant of 87,642 new restricted stock units to a director indicates continued alignment of management incentives with shareholder interests and suggests confidence in the company's future.

Future Outlook

The newly granted 87,642 restricted stock units are scheduled to vest in four equal quarterly installments until the earlier of the first anniversary of the grant date (June 6, 2026) or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, contingent on the director's continued service.

Management Comments

• Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis.
• At vesting, RSUs convert into shares of common stock on a unit-for-share basis, without payment.
• RSUs granted on 09/03/2024 are scheduled to vest as to 1/4 upon grant, and the remaining to vest in equal quarterly installments, until fully vested on the earlier of 06/05/2025 or the day prior to the Issuer's 2025 Annual Meeting of Shareholders, provided that the reporting person continues to serve as a director through each vesting date.
• Each RSU represents a contingent right to receive one share of MicroVision common stock.
• RSUs granted 06/06/2025 are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, provided that the reporting person continues to serve as a director through each vesting date.

Industry Context

This Form 4 filing reflects routine equity compensation for a director, a common practice across industries to align executive and director interests with shareholders. It does not provide broader industry trends or specific competitive insights.

Stakeholder Impact

• Shareholders: Increased alignment of a director's interests with shareholders due to increased equity ownership and future vesting incentives.

Next Steps

• Future vesting of 87,642 RSUs granted on 06/06/2025 in four equal quarterly installments.
• MicroVision's 2026 Annual Meeting of Stockholders, which serves as a potential final vesting date for the newly granted RSUs.

Key Dates

Recommendation

Keywords

MicroVision, MVIS, SEC Form 4, insider trading, beneficial ownership, restricted stock units, RSU, equity grant, director compensation, Peter Schabert